Talasing, Nathaniel A.
HRN: 18-24-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2023
CEFTRIAXONE 1G (VIAL)
11/29/2023
12/06/2023
IV DRIP
1g
OD
PCAP C With Hyperactive Airway Disease
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes